Abstract
Background
Proteases facilitate several steps in cancer progression. To identify proteases most suitable for drug targeting, actual enzyme activity and not messenger RNA levels or immunoassay of protein is the ideal assay readout.
Materials and Methods
An automated microtiter plate assay format was modified to allow detection of all four major classes of proteases in tissue samples. Fifteen sets of colorectal carcinoma biopsies representing primary tumor, adjacent normal colon, and liver metastases were screened for protease activity.
Results
The major proteases detected were matrix metalloproteases (MMP9, MMP2, and MMP1), ca-thepsin B, cathepsin D, and the mast cell serine proteases, tryptase and chymase. Matrix metallopro-teases were expressed at higher levels in the primary tumor than in adjacent normal tissue. The mast cell proteases, in contrast, were at very high levels in adjacent normal tissue, and not detectable in the metastases. Cathepsin B activity was significantly higher in the primary tumor, and highest in the metastases. The major proteases detected by activity assays were then localized in biopsy sections by im-munohistochemistry. Mast cell proteases were abundant in adjacent normal tissue, because of infiltration of the lamina propria by mast cells. Matrix metalloproteases were localized to the tumor cells themselves; whereas, cathepsin B was predominantly expressed by macrophages at the leading edge of invading tumors. Although only low levels of urinary plasminogen activator were detected by direct enzyme assay, immunohistochemistry showed abundant protein within the tumor.
Conclusions
This analysis, surveying all major classes of proteases by assays of activity rather than immunolocalization or in situ hybridization alone, serves to identify proteases whose activity is not completely balanced by endogenous inhibitors and which may be essential for tumor progression. These proteases are logical targets for initial efforts to produce low molecular weight protease inhibitors as potential chemotherapy.
Similar content being viewed by others
References
Imai K, Yokohama Y, Nakanishi I, et al. (1995) Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metallo-proteinases and enzymic properties. J. Biol. Chem. 270: 6691–6697.
Thewes M, Pohlmann G, Atkinson M, Mueller J, Putz B, Hofler H. (1996) Stromelysin-3 (ST-3) mRNA expression in colorectal carcinomas. Localization and clinicopathologic correlations. Diagnostic Mol. Path. 5: 284–290.
Campo E, Munoz J, Miquel R, et al. (1994) Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival [see comments]. Am. J. Path. 145: 301–309.
Gallegos N, Smales C, Savage F, Hembry R, Bou-los P. (1995) The distribution of matrix metallo-proteinases and tissue inhibitor of metallopro-teinases in colorectal cancer. Surg. Oncol. 4: 111–119.
McDonnell S, Navre M, Coffey R, Matrisian L. (1995) Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol. Carcinogen. 4: 527–533.
Murray G, Duncan M, O’Neil, Melvin W, Fothergill. (1996) Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nature Med. 2: 461–462.
Tran-Thang C, Kruithof E, Lahm H, Schuster WA, Tada M, Sordat B. (1996) Modulation of the plasminogen activation system by inflammatory cytokines in human colon carcinoma cells. Brit. J. Cancer 74: 846–852.
Buo L, Bjornland K, Karlsrud TS, et al. (1994) Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines. Anticancer Res. 14: 2445–2451.
Stearns ME, Stearns M. (1996) Immunohisto-chemical studies of activated matrix metallopro-teinase-2 (MMP-2a) expression in human prostate cancer. Oncol. Res. 8: 63–67.
Sinha AA, Wilson MJ, Gleason DF, Reddy PK, Sameni M, Sloane BF. (1995) Immunohisto-chemical localization of cathepsin B in neoplas-tic human prostate. Prostate 26: 171–178.
Sinha AA, Gleason DF, Staley NA, Wilson MJ, Sameni M, Sloane BF. (1995) Cathepsin B in an-giogenesis of human prostate: an immunohisto-chemical and immunoelectron microscopic analysis. Anat. Rec. 241: 353–362.
Hoyhtya M, Fridman R, Komarek D, et al. (1994) Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Intl. J. Cancer 56: 500–505.
Thewes M, Pohlmann G, Atkinson M, Mueller J, Putz B, Hofler H. (1996) Stromelysin-3 (ST-3) mRNA expression in colorectal carcinomas. Localization and clinicopathologic correlations. Diag. Mol. Path. 5: 284–290.
Johnson LD, Hunt DM, Kim K, Nachtigal M. (1996) Amplification of stromelysin-3 transcripts from carcinomas of the colon. Human Path. 27: 964–968.
Miyajima Y, Nakano R, Morimatsu M. (1995) Analysis of expression of matrix metallopro-teinases-2 and −9 inhypopharyngeal squamous cell carcinoma by in situ hybridization. Ann. Otol. Rhinol. Laryngol. 104: 678–684.
Polette M, Clavel C, Birembaut P, De Clerck YA. (1993) Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas. Path. Res. Prac. 189: 1052–1057.
Zeng Z, Guillem J. (1995) Distinct pattern of matrix metalloprotreinase-9 and tissue inhibitor of metalloproteinase-1 mRNA in human col-orectal cancer and liver metastases. Brit. J. Cancer 72: 575–582.
Murata M, Miyashita S, Yokoo C, et al. (1991) Novel epoxysuccinyl peptides. Fed. Eur. Biochem. Soc. 280: 307–310.
Emmert-Buck MR, Roth MJ, Zhuang Z, et al. (1994) Increased gelatinase A (MMP-2) and 460 cathepsin B activity in invasive tumor regions of human colon cancer samples. Am. J. Path. 145: 1285–1290.
Reddy VY, Zhang Q-Y, Weiss SJ. (1995) Pericel-lular mobilization of the tissue-destructive cys-teine proteases cathepsins B, L and S by human monocyte-derived macrophages. Proc. Natl. Acad. Sci. 92: 3849–3853.
Berquin IM, Sloane BF. (1996) Cathepsin B expression in human tumors. Adv. Exp. Med. Biol. 389: 281–294.
Meininger C. (1995) Mast cells and tumor-associated angiogenesis. In Marone G (ed.) Human Basophils and Mast Cells: Clinical Aspects. Kerger, Basel Switzerland, pp. 238–256.
Bashkin P, Razin E, Eldor A, Vlodavsky I. (1990) Degranulating mast cells secrete an en-doglycosidase which degrades heparin sulfate in subendothelial extracellular matrix. Blood 75: 2204–32212.
Vlodavsky I, Eldor A, Haimovitz-Friedman A, et al. (1992) Expression of heparanase by platelets and circulating cells of the immune system: Possible involvement in diapedesis and extravasation. Inv. Metast. 12: 112–127.
Reed JA, Albino AP, McNutt NS. (1995) Human cutaneous mast cells express basic fibroblast growth factor. Lab. Invest. 72: 215–222.
Grutzkau GA, Kruger-Krasagakes S, Baumeister H, et al. (1998) Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol. Biol. Cell. 9: 875–884.
Norrby K, Wooley DE. (1993) Role of mast cells in mitogenesis and angiogenesis in normal tissue and tumor tissue. Adv. Biosci. 89: 71–115.
Blair RJ, Meng H, Marchese MJ, et al. (1997) Human mast cells stimulate vascular tube formation. J. Clin. Invest. 99: 2691–2700.
Gruber BL, Kew RR, Jelaska A, et al. (1997) Human mast cells activate fibroblasts. J. Immunol. 158: 2310–2317.
Fang K, Raymond WW, Blount J, Caughey GH. (1997): Dog mast cell a-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain. J. Biol. Chem. 272: 25628–25635.
Vu TV, Shipley JM, Bergers G, et al. (1998) Matrix metalloproteinase gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93: 411–422.
Acknowledgments
The authors thank William Stetler-Stevenson, Bonnie Sloane, and Ellen Kick for reagents; the UCSF Liver Center Clinical Core for normal human liver samples; Mark Segal, Division of Biostatistics, UCSF, for consultation on statistical analysis; and Ramona Soto for preparation of the manuscript. This work was supported by a National Cancer Institute Program Project Grant #CA72006-02.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by F. E. Cohen.
Rights and permissions
About this article
Cite this article
McKerrow, J.H., Bhargava, V., Hansell, E. et al. A Functional Proteomics Screen of Proteases In Colorectal Carcinoma. Mol Med 6, 450–460 (2000). https://doi.org/10.1007/BF03401787
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03401787